Amgen Inc. (AMGN) Is Surging After Court Upholds Patent For Repatha

Amgen Inc. (AMGN) announced after the close Thursday that the U.S. District Court in Delaware granted the company's request for a permanent injunction prohibiting Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) from infringing two patents that Amgen holds for Repatha.

from RTT - Hot Stocks http://ift.tt/2ik2neQ
via IFTTT